208 related articles for article (PubMed ID: 16523502)
1. Differential activity of the FGF-4 enhancer in F9 and P19 embryonal carcinoma cells.
Boer B; Bernadt CT; Desler M; Wilder PJ; Kopp JL; Rizzino A
J Cell Physiol; 2006 Jul; 208(1):97-108. PubMed ID: 16523502
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of the Oct-3/4 gene in cell culture model systems that parallel different stages of mammalian development.
Mallanna SK; Boer B; Desler M; Rizzino A
Mol Reprod Dev; 2008 Aug; 75(8):1247-57. PubMed ID: 18213644
[TBL] [Abstract][Full Text] [Related]
3. Identification of DPPA4 and other genes as putative Sox2:Oct-3/4 target genes using a combination of in silico analysis and transcription-based assays.
Chakravarthy H; Boer B; Desler M; Mallanna SK; McKeithan TW; Rizzino A
J Cell Physiol; 2008 Sep; 216(3):651-62. PubMed ID: 18366076
[TBL] [Abstract][Full Text] [Related]
4. Distal enhancer of the mouse FGF-4 gene and its human counterpart exhibit differential activity: critical role of a GT box.
Boer B; Luster TA; Bernadt C; Rizzino A
Mol Reprod Dev; 2005 Jul; 71(3):263-74. PubMed ID: 15803454
[TBL] [Abstract][Full Text] [Related]
5. Role of the transcription factor Sox-2 in the expression of the FGF-4 gene in embryonal carcinoma cells.
Johnson LR; Lamb KA; Gao Q; Nowling TK; Rizzino A
Mol Reprod Dev; 1998 Aug; 50(4):377-86. PubMed ID: 9669521
[TBL] [Abstract][Full Text] [Related]
6. Transcription factor Sox-2 inhibits co-activator stimulated transcription.
Bernadt CT; Nowling T; Rizzino A
Mol Reprod Dev; 2004 Nov; 69(3):260-7. PubMed ID: 15349837
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of the murine k-fgf gene.
Rizzino A; Rosfjord E
Mol Reprod Dev; 1994 Sep; 39(1):106-11. PubMed ID: 7999355
[TBL] [Abstract][Full Text] [Related]
8. NF-Y binds to the CCAAT box motif of the FGF-4 gene and promotes FGF-4 expression in embryonal carcinoma cells.
Lamb KA; Johnson LR; Rizzino A
Mol Reprod Dev; 1997 Nov; 48(3):301-9. PubMed ID: 9322240
[TBL] [Abstract][Full Text] [Related]
9. Effects of differentiation on the transcriptional regulation of the FGF-4 gene: critical roles played by a distal enhancer.
Lamb KA; Rizzino A
Mol Reprod Dev; 1998 Oct; 51(2):218-24. PubMed ID: 9740330
[TBL] [Abstract][Full Text] [Related]
10. The Pou5f1/Pou3f-dependent but SoxB-independent regulation of conserved enhancer N2 initiates Sox2 expression during epiblast to neural plate stages in vertebrates.
Iwafuchi-Doi M; Yoshida Y; Onichtchouk D; Leichsenring M; Driever W; Takemoto T; Uchikawa M; Kamachi Y; Kondoh H
Dev Biol; 2011 Apr; 352(2):354-66. PubMed ID: 21185279
[TBL] [Abstract][Full Text] [Related]
11. Constitutive expression of fibroblast growth factor-4 does not alter the growth or the differentiation of embryonal carcinoma cells.
Miller K; Rizzino A
Cell Growth Differ; 1996 Feb; 7(2):203-11. PubMed ID: 8822204
[TBL] [Abstract][Full Text] [Related]
12. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3.
Yuan H; Corbi N; Basilico C; Dailey L
Genes Dev; 1995 Nov; 9(21):2635-45. PubMed ID: 7590241
[TBL] [Abstract][Full Text] [Related]
13. Embryonal carcinoma cell lines stably transfected with mRARbeta2-lacZ: sensitive system for measuring levels of active retinoids.
Sonneveld E; van den Brink CE; van der Leede BJ; Maden M; van der Saag PT
Exp Cell Res; 1999 Aug; 250(2):284-97. PubMed ID: 10413584
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of DNA binding of Sox2 by the SUMO conjugation.
Tsuruzoe S; Ishihara K; Uchimura Y; Watanabe S; Sekita Y; Aoto T; Saitoh H; Yuasa Y; Niwa H; Kawasuji M; Baba H; Nakao M
Biochem Biophys Res Commun; 2006 Dec; 351(4):920-6. PubMed ID: 17097055
[TBL] [Abstract][Full Text] [Related]
15. Binding of transcription factors to widely-separated cis-regulatory elements of the murine FGF-4 gene.
Lamb K; Rosfjord E; Brigman K; Rizzino A
Mol Reprod Dev; 1996 Aug; 44(4):460-71. PubMed ID: 8844688
[TBL] [Abstract][Full Text] [Related]
16. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.
Wang P; Branch DR; Bali M; Schultz GA; Goss PE; Jin T
Biochem J; 2003 Oct; 375(Pt 1):199-205. PubMed ID: 12841847
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid-mediated down-regulation of Oct3/4 coincides with the loss of promoter occupancy in vivo.
Minucci S; Botquin V; Yeom YI; Dey A; Sylvester I; Zand DJ; Ohbo K; Ozato K; Scholer HR
EMBO J; 1996 Feb; 15(4):888-99. PubMed ID: 8631309
[TBL] [Abstract][Full Text] [Related]
18. k-FGF protoncogene expression is associated with murine testicular teratogenesis, but is not involved during mouse testicular development.
de Anta JM; Monzó M; Peris B; Ruano D
Histol Histopathol; 1997 Jan; 12(1):33-41. PubMed ID: 9046041
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells.
Scharnhorst V; Kranenburg O; van der Eb AJ; Jochemsen AG
Cell Growth Differ; 1997 Feb; 8(2):133-43. PubMed ID: 9040935
[TBL] [Abstract][Full Text] [Related]
20. The function of inducible promoter systems in F9 embryonal carcinoma cells.
Miller K; Rizzino A
Exp Cell Res; 1995 May; 218(1):144-50. PubMed ID: 7737354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
